ROTTERDAM, Netherlands (September 9, 2026) – Kemin Biologics, the vaccine business unit of Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of...
ROTTERDAM, Netherlands (August 11, 2026) – Kemin Biologics, the vaccine business unit of Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of...
US$35 million, four-story facility to strengthen Kemin's capabilities and support company's growth in Asia-Pacific region SINGAPORE, July 28, 2026 /PRNewswire/ -- Kemin Industries, a global...